跳至主要内容
临床试验/CTRI/2025/12/099267
CTRI/2025/12/099267尚未招募1/2 期

To study the efficacy of Vidanga extract capsules in dyslipidaemia w.s.r. to Shonitabhishyanda- A double blind randomized controlled clinical trial

Dr Sowmya Bhat1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年12月29日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
To study the efficacy of Vidanga extract in

研究概览

简要总结

Above trial will be conducted in an Ayurveda hospital of Udupi to study the effect of Vidanga extract capsules in dyslipidaemia which is a randomized double blinded controlled clinical trial

Aqueous extract of Vidanga is taken for the purpose of study

Vidanga is a choice of drug mentioned under sthoulya chikitsa in Charaka Samhita

Subjective and Objective Parameters will be studied

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
35.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Individuals diagnosed with dyslipidaemia Age group 35 to 60 years of age Subjects willing to give written consent.

排除标准

  • Hypertension Diabetes mellitus Hypothyroidism Pregnancy and lactation Other systemic illnesses and addictions.

结局指标

主要结局

To study the efficacy of Vidanga extract in

时间窗: 2 months | sample size 40

dyslipidaemia

时间窗: 2 months | sample size 40

次要结局

  • Secondary Objectives:(a) To study the efficacy of Vidanga extract on anthropometric parameters)

研究者

发起方
Dr Sowmya Bhat
申办方类型
Other [Self sponsored ]
责任方
Principal Investigator
主要研究者

Dr Sowmya Bhat

SDM College of Ayurveda Hospital and Research Centre Kuthpady Udupi

研究点 (1)

Loading locations...

相似试验